Techno Trends
Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).
University of Minnesota Develops SpudCell, the First Synthetic Cell with a Complete Life Cycle
Researchers at the University of Minnesota's College of Biological Sciences have developed SpudCell, the world's first synthetic cell capable of completing a full life cycle using only non-living chemical components....
FDA Approves Tregzi as First Regulatory T Cell Therapy for Chronic GVHD Prevention
The U.S. Food and Drug Administration (FDA) has approved Tregzi, the first regulatory T (Treg) cell-based immunotherapy developed to improve chronic graft-versus-host disease (GVHD)-free...
University of Nebraska–Lincoln Develops Adaptable DNA Vaccine Platform to Strengthen Swine Influenza Control
Scientists at the University of Nebraska–Lincoln have introduced a next-generation DNA vaccine platform designed to improve the prevention of swine influenza while reducing manufacturing costs and accelerating vaccine development....
Salanersen Receives FDA Breakthrough Status for Spinal Muscular Atrophy
Biogen has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to salanersen, an investigational treatment for spinal muscular atrophy (SMA)....
University of Cincinnati and Johns Hopkins Develop Nanofibre-Based Therapy for Glioblastoma
Researchers from the University of Cincinnati and Johns Hopkins Medicine have developed a promising nanofibre-based drug delivery system designed to improve treatment outcomes for glioblastoma...
Wenda Pharma Secures Breakthrough Therapy Recognition for NHWD-870 HCI
China’s National Medical Products Administration has granted Zhejiang Wenda Pharmaceutical Technology Co., Ltd. Breakthrough Therapy Designation for NHWD-870 HCI....
Terns Pharmaceuticals Secures FDA Breakthrough Therapy Designation for TERN-701 in CML
Terns Pharmaceuticals, Inc. has received Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration for TERN-701, a novel oral allosteric BCR::ABL1 inhibitor....
FORE Biotherapeutics Receives FDA Breakthrough Therapy Designation for Plixorafenib in Brain Cancer
FORE Biotherapeutics has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for its investigational drug plixorafenib, developed for the treatment of adult patients with BRAF V600E-mutated high-grade glioma, a severe form of brain cancer....
Sanofi Secures FDA Breakthrough Therapy Status for Venglustat in Type 3 Gaucher Disease
The US Food and Drug Administration (FDA) has awarded Breakthrough Therapy designation to venglustat, an investigational oral therapy, for the treatment of neurological symptoms in type 3 Gaucher disease (GD3)....
Cleveland Clinic and Kent State Team Use Quantum Computing to Advance Drug Design
Researchers at the Cleveland Clinic, in collaboration with PhD students from Kent State University, have developed a quantum computing-based method that significantly improves drug design...
